Grants and Contributions:
Title:
Foundational vascularization technologies for engraftment of bioprinted tissues
Agreement Number:
935249
Agreement Value:
$600,276.00
Agreement Date:
Oct 1, 2019 - Sep 30, 2021
Description:
This project will involve the development of novel 3D printing technologies (including hardware, software, biomaterials, and methods) to enable the fabrication of implantable tissues that can engraft and be vascularized in vivo.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2019-2020-Q3-935249
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830167839
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 60,000 dollars.
Amendment Date
Sep 20, 2021
Recipient's Legal Name:
Aspect Biosystems Ltd.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: